Physician
Hematology
Dr. Nathan H. Fowler, MD
|
|
Give Review
Dr. Nathan H. Fowler practices Hematology. He has 1 awards "Most Compassionate Doctor". Nathan Fowler has written publications. He has 36 publications published with PubMed. The lastest paper is: 'AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer.' Nathan Fowler accepts Medicare payments and is listed with Medicare.gov.
Publications
- AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung Cancer.
- Characteristics and management of rash following lenalidomide and rituximab in patients with untreated indolent non-Hodgkin Lymphoma.
- Outcomes After Chemotherapy Followed by Radiation for Stage IIB Hodgkin Lymphoma With Bulky Disease.
- The effect of different rituximab-containing chemotherapy strategies on hepatitis C viremia.
- Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular Lymphoma.
- Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-Cell lymphoma.
- Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory Lymphoma.
- Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin Lymphoma.
- Patients with mantle Cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes.
- Effect of hepatitis C virus infection in patients with Cancer: addressing a neglected population.
- Safety and activity of lenalidomide and rituximab in untreated indolent Lymphoma: an open-label, phase 2 trial.
- Pegylated Liposomal Doxorubicin Replacing Conventional Doxorubicin in Standard R-CHOP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma: An Open Lab...
- Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-Cell non-Hodgkin lymphoma.
- (90) Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-Cell lymphomas, including bulky disease.
- Double hit lymphoma: the MD Anderson Cancer Center clinical experience.
- Primary natural killer/T-Cell lymphoma presenting as leptomeningeal disease.
- Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular Lymphoma: a single group, open-label, phase 2 trial.
- Survival Outcomes of Primary Intraocular Lymphoma: A Single-institution Experience.
- The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin Lymphoma.
- Frontline management strategies for younger, fit patients with mantle Cell lymphoma.
- Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse larg...
- Novel treatment approaches to mantle Cell lymphoma.
- Phase I Study of Panobinostat plus Everolimus in Patients with Relapsed or Refractory Lymphoma.
- Detection of circulating tumour DNA in patients with aggressive B-Cell non-Hodgkin lymphoma.
- Cross Talk between Follicular Th Cells and Tumor Cells in Human Follicular Lymphoma Promotes Immune Evasion in the Tumor Microenvironment.
- Phase I study of vorinostat in combination with standard CHOP in patients with newly diagnosed peripheral T-Cell lymphoma.
- Oral lenalidomide with rituximab in relapsed or refractory diffuse large Cell, follicular and transformed lymphoma: a phase II clinical trial.
- Zoledronic acid for prevention of bone loss in patients receiving primary therapy for Lymphomas: a prospective, randomized controlled phase III trial.
- A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome.
- Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-Cell lymphoma: a phase 1/2 clinical trial.
- Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular Lymphoma: 12-year results.
- Incidence of gastric involvement in patients with nongastrointestinal extranodal marginal zone Lymphoma.
- F-18 FDG PET/CT detecting thyroid plasmacytoma after the successful treatment of gastric large B-Cell lymphoma.
- Developing Novel Strategies to Target B-Cell Malignancies.
- Role of maintenance rituximab (rituxan) therapy in the treatment of follicular Lymphoma.
Schools
Univ Of Tx Med Branch Galveston
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Basal Cell Carcinoma
- Bladder Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- Most Compassionate Doctor
Education
-
Georgetown University Hospital -
University of Texas Medical Branch Hospitals -
University of Texas Medical Branch
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1548475650 | |
| NPPES Provider LastName | FOWLER | |
| NPPES Provider FirstName | NATHAN | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 283.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 18.0 | |
| Percent Opioid Claims | 6.36 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1548475650 |
| Last Name Of The Provider | FOWLER |
| First Name Of The Provider | NATHAN |
| View All |
Similar Doctors
|
|
Dr. Steven M. Kornblau, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Laurent Gressot, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Naveen Pemmaraju, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Qaiser Bashir, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Stewart, MD |
|
|
Dr. Isabella C. Glitza, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel D. Karp, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Mohamed Haq, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert Z. Orlowski, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Michael A. Davies, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pei Lin, MD |
|
Dr. Charles E. Manner Jr., MD
This Doctor is OpenDoctor Recommended.
|